Netherlands - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care
Since 2014, Netherlands Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care fell by 1.2% year on year. With €10.59 Per Capita in 2019, the country was ranked number 7 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care. Netherlands is overtaken by Cyprus, which was ranked number 6 with €12.41 Per Capita and is followed by Belgium at €9.79 Per Capita. Liechtenstein topped the ranking with €414.92 Per Capita in 2019, that is a growth of 4.3% compared to 2018. Switzerland, Austria and Italy respectively ranked number 2, 3 and 4 in this ranking. Belgium recorded the best 5 years average growth at +81.3% per year, while Ireland was the worst growing country at -18.1% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 10.59 |
2018 | 11.03 |
2017 | 11.09 |
2016 | 11.16 |
2015 | 11.22 |
How does Netherlands rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Providers of Ambulatory Health Care?
# | 17 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Liechtenstein
|
414.92 | 2019 | +4.3 % | +0.9 % | View data | |
2 |
#2
Switzerland
|
309.49 | 2019 | +2.7 % | +6.9 % | View data | |
6 |
#6
Cyprus
|
12.41 | 2019 | -2.7 % | -0.2 % | View data | |
7 |
#7
Netherlands
|
10.59 | 2019 | -4.0 % | -1.2 % | View data | |
8 |
#8
Belgium
|
9.79 | 2019 | +8.2 % | +81.3 % | View data |